ELI A. FRIEDMAN, M.D.; BARBARA G. DELANO, M.D.
To the editor: Uncontrolled trials of dialytic therapy in psoriasis (1-3) have recently indicated remarkable improvement in skin lesions and well being. The rationale for beneficial peritoneal or hemodialysis in psoriasis is the extraction of "noxious exogenous or endogenous substance(s)" or, alternatively, "absorption of some beneficial substance from dialysis solution" (1). Because psoriasis is a disease that "in some patients may undergo spontaneous improvement . . ." (4) the effect, if any, of dialysis may be difficult to interpret. We report the case of a patient who, while undergoing effective and adequate maintenance hemodialysis, developed typical psoriasis.
A 58-year-old married
Learn more about subscription options.
Register Now for a free account.
FRIEDMAN EA, DELANO BG. Psoriasis Developing De Novo During Hemodialysis. Ann Intern Med. 1979;90:132. doi: 10.7326/0003-4819-90-1-132_1
Download citation file:
Published: Ann Intern Med. 1979;90(1):132.
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only